Upadacitinib Induction and Maintenance Therapy for Crohn's Disease

Loftus, EV; Panés, J; Lacerda, AP; Peyrin-Biroulet, L; D'Haens, G; Panaccione, R; Reinisch, W; Louis, E; Chen, MH; Nakase, H; Begun, J; Boland, BS; Phillips, C; Mohamed, MEF; Liu, JZ; Geng, ZQ; Feng, T; Dubcenco, E; Colombel, JF

Colombel, JF (通讯作者)，Icahn Sch Med Mt Sinai, Dept Med, Henry D Janowitz Div Gastroenterol, 1470 Madison Ave, New York, NY 10029 USA.

NEW ENGLAND JOURNAL OF MEDICINE, 2023; 388 (21): 1966

Abstract

BACKGROUND Upadacitinib, an oral selective Janus kinase ( JAK) inhibitor, is under investigation for the treatment of Crohn's disease. METHODS In two ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索